RE:Partial answer to PanCan funding mystery lies with grant floThe full House responded in support and the FY 24 Defense Appropriations Act was passed by the House with $20 million dedicated to pancreatic cancer research. While this is a critical milestone, PanCAN will continue to advocate to ensure the increase is included as the bill moves through next steps with the Senate and conference negotiations.
“... the money isn’t in the hands of researchers yet and we encourage Congress to work in a bi-partisan manner to complete their work on a FY 24 spending deal that includes $20 million in dedicated funding for pancreatic cancer.”